IN2014MU00858A - - Google Patents

Info

Publication number
IN2014MU00858A
IN2014MU00858A IN858MU2014A IN2014MU00858A IN 2014MU00858 A IN2014MU00858 A IN 2014MU00858A IN 858MU2014 A IN858MU2014 A IN 858MU2014A IN 2014MU00858 A IN2014MU00858 A IN 2014MU00858A
Authority
IN
India
Prior art keywords
compound
formula
preparation
disclosed
Prior art date
Application number
Other languages
English (en)
Inventor
Vijay Prakash Chavan
Karuna Suresh Wankhede
Vikas Vithalrao Deshmukh
Satish Bhawsar
Kiran Ramchandra Patil
Ravindra Dattatraya Yeole
Prasad Keshav Deshpande
Mahesh Vithalbhai Patel
Original Assignee
Wockhardt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wockhardt Ltd filed Critical Wockhardt Ltd
Priority to IN858MU2014 priority Critical patent/IN2014MU00858A/en
Priority to US15/125,554 priority patent/US9790223B2/en
Priority to JP2016574517A priority patent/JP2017513926A/ja
Priority to CN201580014017.5A priority patent/CN106458896A/zh
Priority to PCT/IB2015/051794 priority patent/WO2015136473A1/en
Priority to MX2016011903A priority patent/MX2016011903A/es
Priority to KR1020167026620A priority patent/KR20160132414A/ko
Priority to EP15718590.1A priority patent/EP3116875A1/en
Publication of IN2014MU00858A publication Critical patent/IN2014MU00858A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C249/00—Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C249/04—Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton of oximes
    • C07C249/08—Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton of oximes by reaction of hydroxylamines with carbonyl compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/32—Oximes
    • C07C251/34—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C251/36—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with the carbon atoms of the oxyimino groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Cephalosporin Compounds (AREA)
IN858MU2014 2014-03-14 2015-03-12 IN2014MU00858A (zh)

Priority Applications (8)

Application Number Priority Date Filing Date Title
IN858MU2014 IN2014MU00858A (zh) 2014-03-14 2015-03-12
US15/125,554 US9790223B2 (en) 2014-03-14 2015-03-12 Process for preparation of sodium (2S,5R)-6-(benzyloxy)-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carboxylate
JP2016574517A JP2017513926A (ja) 2014-03-14 2015-03-12 ナトリウム（２ｓ，５ｒ）−６−（ベンジルオキシ）−７−オキソ−１，６−ジアザビシクロ［３．２．１］オクタン−２−カルボキシレートを調製する方法
CN201580014017.5A CN106458896A (zh) 2014-03-14 2015-03-12 (2s,5r)‑6‑(苄氧基)‑7‑氧代‑1,6‑二氮杂二环[3.2.1]辛烷‑2‑羧酸钠的制备方法
PCT/IB2015/051794 WO2015136473A1 (en) 2014-03-14 2015-03-12 A process for preparation of sodium (2s, 5r)-6-(benzyloxy)-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carboxylate
MX2016011903A MX2016011903A (es) 2014-03-14 2015-03-12 Un procedimiento para la preparacion de (2s, 5r) -6- (benciloxi) -7-oxo-1,6-diazabiciclo [3.2.1] octan-2-carboxilato de sodio.
KR1020167026620A KR20160132414A (ko) 2014-03-14 2015-03-12 소듐 (2s, 5r)-6-(벤질옥시)-7-옥소-1,6-다이아자바이사이클로[3.2.1]옥테인-2-카복실레이트의 제조 공정
EP15718590.1A EP3116875A1 (en) 2014-03-14 2015-03-12 A process for preparation of sodium (2s, 5r)-6-(benzyloxy)-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carboxylate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN858MU2014 IN2014MU00858A (zh) 2014-03-14 2015-03-12

Publications (1)

Publication Number Publication Date
IN2014MU00858A true IN2014MU00858A (zh) 2015-09-25

Family

ID=53005597

Family Applications (1)

Application Number Title Priority Date Filing Date
IN858MU2014 IN2014MU00858A (zh) 2014-03-14 2015-03-12

Country Status (8)

Country Link
US (1) US9790223B2 (zh)
EP (1) EP3116875A1 (zh)
JP (1) JP2017513926A (zh)
KR (1) KR20160132414A (zh)
CN (1) CN106458896A (zh)
IN (1) IN2014MU00858A (zh)
MX (1) MX2016011903A (zh)
WO (1) WO2015136473A1 (zh)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2222638A2 (en) 2007-11-21 2010-09-01 Decode Genetics EHF Biaryl pde4 inhibitors for treating inflammation
US20120053350A1 (en) * 2009-04-30 2012-03-01 Ian Mangion Preparation of alkyl esters of n-protected oxo-azacycloalkylcarboxylic acids
US8772490B2 (en) * 2010-12-22 2014-07-08 Meiji Seika Pharma Co., Ltd. Optically active diazabicyclooctane derivatives and process for preparing the same
MX361020B (es) * 2011-06-17 2018-11-26 Pfizer Anti Infectives Ab Procesos para preparar compuestos heterociclicos, incluida trans-7-oxo-6-(sulfooxi)-1,6-diazabiciclo [3,2,1]octano-2-carboxam ida y sales de la misma.
TW201343646A (zh) * 2012-03-30 2013-11-01 Cubist Pharm Inc 異□唑β－內醯胺酶抑制劑
US9862718B2 (en) 2013-03-08 2018-01-09 Wockhardt Limited Sodium salt of (2S, 5R)-6-benzyloxy-7-oxo-1,6-diaza-bicyclo [3.2.1] octane-2-carboxylic acid and its preparation
WO2015052682A1 (en) 2013-10-11 2015-04-16 Wockhardt Limited Nitrogen containing compounds and their use

Also Published As

Publication number Publication date
MX2016011903A (es) 2016-12-05
JP2017513926A (ja) 2017-06-01
US20170008892A1 (en) 2017-01-12
WO2015136473A1 (en) 2015-09-17
US9790223B2 (en) 2017-10-17
CN106458896A (zh) 2017-02-22
EP3116875A1 (en) 2017-01-18
KR20160132414A (ko) 2016-11-18

Similar Documents

Publication Publication Date Title
MX2020001278A (es) Sintesis de compuestos de carbamoilpiridona policiclica.
NZ726356A (en) Processes for preparing antiviral compounds
GR20140100479A (el) Συνθεση λιραγλουτιδης
AU2016277367A8 (en) Aryl sulfonohydrazides
IN2014CH00247A (zh)
MX2017002214A (es) Proceso para la preparacion de 5-fluoro-1h-pirazoles partiendo de hexafluoropropeno.
MX2020003020A (es) Compuestos de aminocarbonilcarbamato.
MX2016015543A (es) Proceso para la preparacion de 5-fluoro-1h-pirazoles a partir de hexafluoropropeno.
MA39843A (fr) Pyridine-2-amides utiles comme agonistes de cb2
PH12018550165A1 (en) An improved process for the preparation of butorphanol tartrate
IN2014MU01192A (zh)
IN2014MU00195A (zh)
MX2015013589A (es) Proceso e intermediario para la preparacion de pregabalina.
MX2016015624A (es) Proceso para la preparacion de derivados de tiazol.
MX2019004024A (es) Metodo para preparar acetofenonas sustituidas con ciclopropilo.
IN2014MU00194A (zh)
IN2014MU01196A (zh)
MX2016016398A (es) Preparacion de piperidin-4-carbotioamida.
MX2016015623A (es) Proceso para la preparacion de derivados dihidroisoxazol.
MX2017002609A (es) Procedimiento mejorado para la preparacion de lacosamida y su intermediario novedoso.
IN2014CH00444A (zh)
CL2016002925A1 (es) Procedimiento mejorado para preparar ácidos crotónicos sustituidos
IN2014MU00858A (zh)
IN2014MU01195A (zh)
IN2014MU00072A (zh)